Suppr超能文献

在没有激肽释放酶的情况下,通过Hageman因子的作用从高分子量激肽原释放激肽。

Kinin release from high molecular weight kininogen by the action of Hageman factor in the absence of kallikrein.

作者信息

Wiggins R C

出版信息

J Biol Chem. 1983 Jul 25;258(14):8963-70.

PMID:6553057
Abstract

Proteolysis of 125I-high molecular weight (Mr) kininogen occurred in kaolin-activated plasma which was deficient in prekallikrein, but not in plasma which lacked both prekallikrein and Hageman factor (HF) activity. The implication of this observation is that HF itself might be capable of releasing kinin from high Mr kininogen. This concept was further supported by the following studies. In a purified protein system rabbit (Mr = 80,000) two-chain activated HF (alpha-HFa) incubated with human 125I-high Mr kininogen caused rapid proteolysis of the kininogen in the presence, but not in the absence, of kaolin. This was in contrast to the effect of kallikrein on proteolysis of high Mr kininogen which was inhibited 10-fold by the presence of kaolin. The possibilities that the alpha-HFa preparation was contaminated by rabbit kallikrein or that the human high Mr kininogen preparation was contaminated by human prekallikrein were excluded by using specific antibodies (IgG) against these proteins. The proteolytic fragments of 125I-high Mr kininogen generated by both alpha-HFa and kallikrein were indistinguishable by sodium dodecyl sulfate-polyacrylamide gel analysis. Bioassayable kinin was released from high Mr kininogen following incubation with alpha-HFa in the presence of kaolin. The amount of kinin released in proportion to the extent of proteolysis was the same for both kallikrein and alpha-HFa. The data show that activated Hageman factor may cause release of kinin by proteolytic cleavage of high Mr kininogen. This phenomenon occurs not only in a purified system of proteins but also in kaolin-activated plasma.

摘要

125I标记的高分子量激肽原在缺乏前激肽释放酶的高岭土激活血浆中发生了蛋白水解,但在既缺乏前激肽释放酶又缺乏Hageman因子(HF)活性的血浆中未发生。这一观察结果提示HF本身可能能够从高分子量激肽原中释放激肽。以下研究进一步支持了这一概念。在纯化的蛋白质系统中,将兔(分子量 = 80,000)双链活化HF(α-HFa)与人125I标记的高分子量激肽原一起孵育,在有高岭土存在时会导致激肽原迅速发生蛋白水解,而在无高岭土时则不会。这与激肽释放酶对高分子量激肽原蛋白水解的作用形成对比,激肽释放酶的作用在有高岭土存在时会被抑制10倍。通过使用针对这些蛋白质的特异性抗体(IgG),排除了α-HFa制剂被兔激肽释放酶污染或人高分子量激肽原制剂被人前激肽释放酶污染的可能性。通过十二烷基硫酸钠 - 聚丙烯酰胺凝胶分析,α-HFa和激肽释放酶产生的125I标记的高分子量激肽原的蛋白水解片段无法区分。在有高岭土存在的情况下,与α-HFa孵育后,可从高分子量激肽原中释放出具有生物活性的激肽。激肽释放酶和α-HFa释放的激肽量与蛋白水解程度成正比。数据表明,活化的Hageman因子可能通过对高分子量激肽原的蛋白水解裂解导致激肽释放。这种现象不仅发生在纯化的蛋白质系统中,也发生在高岭土激活的血浆中。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验